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Objective: To investigate the natural course of persistent pulmonary
subsolid nodules (SSNs) with solid portions ≤5mm and whether
“follow-up and surgical resection after interval growth” can have
negative influence on recurrence or overall death in patients with
persistent PSNs with solid component ≤ 5mm.
Methods: From 2005 to 2013, the natural courses of 213 persistent
SSNs in 213 patients were evaluated. To identify significant
predictors of the interval growth, Kaplan-Meier analysis and Cox
proportional hazard regression analysis were performed. Meanwhile,
125 part-solid nodules (PSNs) were evaluated for disadvantage of
delay in surgical resection only after the sole evidence of interval
growth on patient outcomes, using Cox-regression analysis.
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Results: Among the 213 nodules, 136 were pure ground-glass
nodules (GGNs) (growth, 18; stable, 118) and 77 were part-solid
GGNs with solid portions ≤5mm (growth, 24; stable, 53). For all
SSNs, lung cancer history (p=0.001), part-solid GGNs (p<0.001), and
nodule diameter (p<0.001) were significant predictors for the interval
growth. On subgroup analysis, nodule diameter was an independent
predictor for the interval growth of both pure GGNs (p<0.001), and
part-solid GGNs (p=0.037). For part-solid GGNs, lung cancer history
(p=0.002) was another significant predictor of the interval growth.
Interval growth of pure GGNs ≥10mm and part-solid GGNs ≥8mm
were significantly more frequent than in pure GGNs <10mm
(p<0.001) and part-solid GGNs <8mm (p=0.003), respectively. With
respect to prognosis in PSNs, There were five equivocal cases of
recurrences. However, even if these 5 equivocal cases were actually
recurrences, there were no significant differences between these two
groups in terms of recurrence-free survival (p=0.485) and overall
survival (p=0.185).
Conclusion: Natural course of SSNs with solid portions ≤5mm
differed significantly according to their nodule type and nodule
diameters, with which their managements can be subdivided. And
“follow-up and surgical resection after interval growth” did not show
negative influence on prognosis of patients with persistent PSNs with
solid components ≤ 5mm.
----------------------------------------------------------
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Introduction
Persistent pulmonary subsolid nodules (SSNs) that persist or grow
over follow-up examinations of 3 months or longer can be
categorized into pure ground-glass nodules (GGNs) and part-solid
GGNs (1). Barring a few exceptions, they pathologically represent
invasive pulmonary adenocarcinoma or their preinvasive lesions such
as atypical adenomatous hyperplasia (AAH), or
adenocarcinoma-in-situ (AIS) (1-3), and along with the increased
utilization of CT in lung cancer screening and in daily clinical
practice, the detection of these SSNs is expected to increase (2).
According to recent Fleischner Society guidelines, persistent subsolid
nodules are categorized into three groups, pure ground-glass nodules
(GGNs), part-solid nodules (PSNs) with solid component ≤ 5mm,
and PSNs with solid component > 5mm (1). They recommend yearly
surveillance follow-up CT for persistent pure GGNs larger than 5
mm, and suggest that part-solid GGNs with solid portions ≤ 5 mm
may also be followed-up with yearly surveillance CT, as these
nodules show a markedly indolent clinical course and a substantial
proportion of these nodules may not be clinically relevant
malignancies (1). However, such conservative management on these
nodules with high malignancy potential can take a risk of stage shift
and worse prognosis due to the resultant treatment delay. Indeed, one
retrospective study reported that a delay in surgical resection only
after the sole evidence of interval growth had no adverse effect on
patient outcomes (4).
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Several previous studies have also investigated the natural course of
SSNs and reported its indolent clinical course as well as various
clinico-radiological factors that can be utilized to predict the interval
growth of these nodules (2, 5-15). However, although pure and
part-solid GGNs can show very distinct clinical behaviors with
different malignant probabilities (1, 16), these studies analyzed pure
GGNs and part-solid GGNs altogether without separate
sub-classification, or arbitrarily decided the cut-off values for the
evaluation of SSNs without elaborate categorization. In addition, there
have been no studies that have evaluated the natural course of
persistent SSNs with solid portions ≤ 5 mm, classified in the new
Fleischner Society’s guidelines, and investigated the predictors for
interval growth of these nodules over follow-ups. Moreover, there has
been no study dealing with whether there would be any difference
regarding disease recurrence or patients’ survival between “follow-up
and surgical resection only after interval growth” and “immediate
surgical resection” in patients with persistent PSNs with solid
component ≤ 5mm. Therefore, our study aimed to investigate the
natural course of persistent pulmonary SSNs with solid portions ≤ 5
mm and whether “follow-up and surgical resection after interval
growth” can have negative influence on recurrence or overall death in
patients with persistent PSNs with solid component ≤ 5mm.
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MATERIALS AND METHODS
This retrospective study was approved by the institutional review
board of Seoul National University Hospital with a waiver of the
requirement for patients’ informed consent.
Natural course of persistent pulmonary SSNs
with solid portions ≤ 5 mm
A search of our hospital’s Ground-Glass Nodule registry (17-20)
between May 2005 and February 2013 was conducted. Two
radiologists (J.H.L. and C.M.P., with 4 and 17 years of experience in
thoracic radiology) reviewed all chest CT images of this registry and
patients who met all of the following criteria comprised our study
population: Patients with (a) SSNs confirmed as persistent on
follow-up CTs with a follow-up interval of 3 months or longer, (b)
SSNs ranging in diameter from 5 mm to 3 cm on their initial CTs,
(c) solid portions within SSNs, if any, 5 mm or smaller, and (d)
initial chest CTs demonstrating SSNs with slice thicknesses ≤ 1.25
mm. Solid portions referred to the part of SSN showing increased
attenuation to the degree of obscuring the underlying pulmonary
vessels and airway walls within it. In this study, we used the
“average diameter” for SSNs’ diameter, which is defined as the
average between the longest diameter of the SSNs and their
perpendicular short-axis diameter on axial CT images based on
Fleischner Society recommendations (1). The size of part-solid GGNs’
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solid portions was measured in its largest dimension. When patients
had multiple SSNs, only one dominant SSN was included according
to the following criteria: (a) Part-solid GGNs receive higher priority
than pure GGNs, (b) when there are two or more part-solid GGNs,
the nodule with the largest solid portion was selected, (c) when size
of solid components was similar, a PSN with the largest size was
selected, and (d) a pure GGN with the largest diameter was selected,
if there were no part-solid GGNs.
Finally, 213 persistent SSNs in 213 patients (mean age, 57.88 ±
10.38 years; range 24 - 87 years) were included in this study
(median follow-up duration, 849 days; range, 90 – 2900 days). Of the
213 patients, 72 were men (mean age, 59.10 ± 9.88 years; range 24 -
87 years) and 141 were women (mean age, 57.26 ± 10.6 years; range
24 - 80 years).
One author (S.M.L., with 10 years of experience in thoracic
radiology) searched the electronic medical records and the radiology
information systems of our hospital for the clinical and demographical
features of the study patients including sex, age, smoking history,
lung cancer history, as well as a history of other cancers. If the
patients had a cancer history, the author investigated whether the
SSNs were detected synchronously or metachronously. Pathological
diagnoses of the surgically resected SSNs were also recorded. All
chest CT images were viewed by two radiologists (J.H.L. and
C.M.P.) in consensus. The initial and all follow-up CT images were
displayed side-by-side on monitors using the Picture Achieving and
Communication Systems, and were compared. All SSNs and their
solid portions were evaluated through visual assessment at the lung
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window setting (a level of -700 Hounsfield units and a width of 1500
Hounsfield units). The nodule type of SSNs (pure GGNs or part-solid
GGNs), multiplicity, location of SSNs and diameters of SSNs on
initial CT and follow-up CTs were also recorded. In this study,
interval growth of SSNs was designated when one of the following
was observed: (a) a size increase of ≥ 2 mm in diameter was
identified on follow-up CTs compared with initial CT (21), (b) solid
portions in part-solid GGNs increased by 2 mm or greater compared
to the initial CT, or (c) solid portions newly occurred within the pure
GGNs (1, 5-9).
After that, all 213 SSNs were analyzed using Kaplan-Meier
analyses with the log-rank test based on the clinico-radiologic
features described above. To determine the independent predictors of
interval growth, multivariate Cox proportional hazard regression
analysis with backward stepwise selection was performed using input
variables with P-values < 0.10 at the log-rank test. Backward
stepwise selection was conducted with iterative entry of variables
based on the test results (p<0.05), and the removal of variables was
based on likelihood ratio statistics with a probability of 0.10.
Subsequently, the 213 SSNs were categorized into pure GGNs and
part-solid GGNs with solid parts ≤ 5 mm, and subgroup analysis
was performed separately for each group in the same statistical
manner as described above, as these two groups have been reported
to have different malignancy probabilities, and assumingly different
natural courses (1, 16). In the part-solid GGN group, the cut-off
value of the solid portion was determined using ROC curve analysis.
Among the significant variables on the Cox proportional hazards
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model, nodule diameter was selected for further categorization. For
each type of SSN, we divided the patients into three groups
according to their diameter on initial CT (<8mm; 8-10mm; ≥10mm)
and post hoc power analysis was performed for the results of
Kaplan-Meier analyses with the log-rank test to confirm the most
significant cut-off diameter for growth. Finally, the annual cumulative
percentages of growing nodules were analyzed with respect to the
determined cut-off diameters in pure GGN and part-solid GGN
groups.
Prognosis comparison between “follow-up and
surgical resection only after interval growth” and
“immediate surgical resection” in patients with
persistent PSNs with solid portions ≤ 5mm
One author (J.H.L.) searched the lung parenchymal operation records
of our hospital between April 2006 and February 2015 and selected all
pathologic information with the descriptive terms “pulmonary
adenocarcinoma”, “minimally invasive adenocarcinoma”, or preinvasive
lesion such as “atypical adenomatous hyperplasia”, “adenocarcinoma
in-situ” or “bronchioloalveolar carcinoma”. A total of 2959 pathologies
were identified and two radiologists (J.H.L. and C.M.P.) reviewed all
pre-operation chest CT images of these 2959 pathologies. Lesions
which met all of the following criteria comprised our study
population: Lesions with (a) appearance of PSNs ranging in size from
5mm to 30mm on initial chest CT and persistent over short-term
follow-up 3months or shorter, (b) solid components within PSNs,
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5mm or smaller on initial CT, (c) initial chest CTs demonstrating
PSNs with slice thicknesses ≤ 1.25 mm, (d) available post-operative
CT scans to evaluate patients’ postoperative disease status. When one
patient had multiple PSNs with solid component ≤ 5mm, only one
dominant nodule was included in the same manner as described
above. A total of 144 patients with 144 PSNs with solid parts 5mm
or smaller were selected. Among this population, 19 patients with 19
PSNs (median follow-up period, 255 days; range 123 – 1150 days)
which were followed-up and surgically resected later without
evidence of interval growth on follow-up CTs, were excluded in this
study since this study aimed to investigate whether there would be
any difference regarding disease recurrence or patients’ survival
between “follow-up and surgery only after interval growth” and
“immediate surgery” in patients with persistent PSNs with solid
component ≤ 5mm.
Thus, 125 individuals (men:women=41:84; mean age, 59.9 ± 9.1
years; range 38 - 80 years) with 125 PSNs (mean diameter, 13.16 ±
5.32mm; range, 5 – 29.7mm) were finally included in this study
(figure 1) and they were categorized into two groups (interval growth
group vs. immediate surgery group). The interval growth group is
defined as PSNs which are designated when one of the growth
indications as described above. The immediate surgery group is
referred to group of the nodules with just short-term follow-up CT
demonstrating persistency of the nodules. Among the 125 patients, 54
patients were classified into “interval growth group” (median
follow-up period before surgery, 554 days; range, 90 – 3222 days)
and the remaining 71 were categorized into “immediate surgery
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group” (median follow-up period before surgery, 49 days; range, 25
– 91 days).
One author (J.H.L.) searched the electronic medical records and the
radiology information systems of our hospital for the clinical and
demographical features of this study population including age, sex,
smoking history, and history of malignancy. Pathological diagnoses
and stages of the surgically resected PSNs were also recorded. In
addition, the individuals’ survivals were investigated. Two radiologists
(J.H.L. and C.M.P.) reviewed all pre- and post-operation chest CT
images in consensus. All PSNs and their solid components were
evaluated through visual assessment at the lung window setting (a
level of -700 Hounsfield units and a width of 1500 Hounsfield units).
Multiplicity, location of PSNs and sizes of the nodules and their solid
components on initial CT and pre-operation follow-up CTs were
recorded. As for interval growth group, clinical tumor stage shift was
evaluated both based on whole nodule size and solid component’ size.
For evaluation of recurrence, all follow-up chest CTs after surgery
were evaluated at both lung and mediastinal window setting (a level
of 30 Hounsfield units and a width of 400 Hounsfield units).
Independent t-test, Wilcoxon rank sum test, Chi-square test, and
Fisher’s exact test were performed to analyze mean and proportions
of baseline clinical and radiological findings of the two groups, as
appropriate. To evaluate the influence of follow-up till interval growth
on recurrence and survival, Cox proportional hazard model was
performed (22). To control the potentially different baseline
characteristics between these two groups, rigorous adjustment for the
variables was conducted. For the continuous variables including age,
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size of the nodules, and solid components, restricted cubic spline
regression was performed for linearity assumption and proportional
hazard assumption (23-25). Sex, history of malignancy, smoking
history, location and position of the nodules, and multiplicity were
modeled as categorical variables, and log-log survival plot was used
for proportional hazard assumption. A P value < 0.05 was considered
to indicate a statistical significance, with all statistical analyses
performed using SPSS ver. 20.0 (SPSS Inc., Chicago, IL, USA) and
MedCalc ver. 12.0 (MedCalc Software, Mariakerke, Belgium).
Seven different CT scanners were used in this study (Sensation
16, SOMATOM Definition, Siemens Medical Solutions, Forchheim,
Germany; Brilliance-64, Ingenuity, Phillips Medical Systems, Best,
Netherlands; Aquilion One, Toshiba, Japan; Discovery CT750 HD,
LightSpeed Ultra, GE Medical Systems, Waukesha, Wis). All CT
examinations were performed with the following parameters: 120 kVp;
60-90 mAs; pitch of 0.75 - 1.5; and collimation of 0.625 - 1.25mm.
All image data were reconstructed using the medium-sharp
reconstruction algorithm with a thickness of 1.25mm or less. CT
scans were performed in the supine position at full inspiration. In the
case of contrast-enhanced CT, 100 mL of contrast medium was
injected at a rate 2 mL/sec. Intervals between follow-up CTs after
confirmation of SSNs’ persistency were decided upon at the referring




Natural course of persistent pulmonary SSNs
with solid portions ≤ 5 mm
Clinical and initial radiological characteristics of the 213 patients and
213 persistent SSNs are summarized in Table 1. Among the 213
SSNs, 136 were pure GGNs, and 77 were part-solid GGNs with solid
portions ≤ 5 mm on initial chest CT scans. With respect to nodule
growth, 42 nodules were classified to have shown growth and 171
were determined to have remained stable. Among the 42 SSNs
classified as having shown growth, nodule size increased in 22, new
solid portions occurred within the SSNs in 4, internal solid portions
increased in 4, and the remaining 12 showed a combination of these
patterns. For follow-up duration, there were 165, 112, 63, 40, and 24
nodules at 1, 2, 3, 4, 5 year’s follow-up, respectively, and 24 nodules
had been followed-up for more than 5 years.
Among the 213 nodules, 58 nodules were surgically resected (median
follow-up period before surgical resection, 557 days; range, 94 –
2903 days). Fourteen were invasive adenocarcinomas (pure GGN in 3,
part-solid GGN in 11), 5 were minimally invasive adenocarcinomas
(MIA) (pure GGN in 4, part-solid GGN in 1), 30 were AIS (pure
GGN in 19, part-solid GGN in 11), and 9 were AAH (pure GGN in 7,
part-solid GGN in 2). Twenty-seven of the 58 nodules were judged
to have shown growth prior to surgical resection and were confirmed
as invasive adenocarcinomas (n=5), MIA (n=3), AIS (n=17), and AAH
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(n=2), pathologically. The remaining 31 of the 58 nodules consisting
of 19 pure GGNs and 12 part-solid GGNs were resected without
evidence of growth. The mean diameter of these 19 pure GGNs and
12 part-solid GGNs were 8.88 mm (range, 5.0 - 14.4 mm) and 9.3
mm (range, 5.1 - 15.3 mm), respectively. Pathologically, 19 pure
GGNs turned out to be AAH (n=5), AIS (n=9), MIA (n=2), and
invasive adenocarcinomas (n=3). As for the 12 part-solid GGNs, there
were 2 AAH, 4 AIS, and 6 invasive adenocarcinomas. Meanwhile, the
15 SSNs showing interval growth on follow-ups (median, 19 months;
range, 3 - 63 months) were not resected owing to several reasons
such as patient's refusal of surgery (n=10) or loss of follow-up
(n=5). These 15 nodules consisted of 4 pure GGNs (mean diameter,
9.08 mm; range, 7.4 - 12.3 mm) and 11 part-solid GGNs (mean
diameter, 11.45 mm; range, 5.7 - 17.8 mm).
On Kaplan-Meier analysis with the log-rank test, lung cancer
history (p=0.002), nodule type of SSNs (p<0.001) (Figure 2a), and the
diameter of SSNs (p<0.001) were shown to be significant variables
for SSN growth. Subsequent Cox proportional hazard regression
analysis revealed that lung cancer history (Hazard ratio (HR), 3.884;
p=0.001), part-solid GGNs (HR, 3.570; p<0.001), and the diameter of
SSNs (HR, 3.576; p<0.001) were independent predictors for interval
growth of SSNs.
Table 2 demonstrates the results of univariate and multivariate
analyses on the growth of pure GGNs. The diameter of pure GGNs
(p<0.001) was a single significant variable associated with interval
growth on Kaplan-Meier analysis with the log-rank test. Subsequent
Cox regression analysis also revealed that their diameter (HR, 6.620;
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p<0.001) was the only significant predictor for the interval growth of
pure GGNs. According to the analysis of the three subgroups based
on SSN diameters (<8mm; 8-10mm; ≥10mm), a cut-off value of 10
mm was determined to be the most significant cut-off diameter in
terms of nodule growth (p<0.001, p=0.013). The annual cumulative
percentages of growing pure GGNs with a cut-off value of 10 mm is
demonstrated in Table 3. Pure GGNs ≥ 10 mm on initial CT showed
significantly more frequent interval growth than pure GGNs < 10 mm
(12.9% vs. 1.9%, 30.4% vs. 4.0%, 42.0% vs. 10.9%, 42.0% vs. 13.5%,
71.0% vs. 13.5%, at 1, 2, 3, 4 and 5 year’s follow-up, respectively;
p<0.001) (Figures 2b).
Univariate and multivariate analyses on the growth of part-solid
GGNs with solid portions ≤ 5 mm are summarized in Table 4. The
log rank test revealed that patient’s age (p=0.043), lung cancer history
(p<0.001), diameter of part-solid GGNs (p=0.003), and solid portion
size (p<0.001) were significant variables associated with interval
growth. Subsequent Cox regression analysis demonstrated that lung
cancer history (HR, 5.917; p=0.002) and diameter of part-solid GGNs
(HR, 2.749; p=0.037) were independent predictors for interval growth
of part-solid GGNs, while the size of the solid portion (HR, 2.394;
p=0.094) did not show statistical significance. According to the
analyses of the three groups based on their diameters (<8mm;
8-10mm; ≥10mm), the most significant cut-off diameter in terms of
nodule growth was 8 mm (p=0.014, p=0.011). The annual cumulative
percentages of part-solid GGNs showing growth with a cut-off value
of 8 mm is presented in Table 3. Part-solid GGNs ≥ 8 mm had a
significantly higher frequency of interval growth than those < 8 mm
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(11.5% vs. 11.5%, 38.0% vs. 21.5%, 43.6% vs. 21.5%, 78.9% vs. 21.5%,
78.9% vs. 21.5%, at 1, 2, 3, 4 and 5 year’s follow-up, respectively;
p=0.003) (Figures 2c).
Prognosis comparison between “follow-up and
surgical resection only after interval growth” and
“immediate surgical resection” in patients with
persistent PSNs with solid portions ≤ 5mm
The baseline clinical and CT characteristics for 125 PSNs of 125
individuals and the comparison between the two groups were
summarized in the table 5. Among the 54 PSNs of interval growth
group, nodule size increased in 30 (mean increase of size, 3.96 ±
1.54mm; range, 2.1 – 7.0mm), internal solid parts increased in 10
(mean increase of solid parts, 3.8 ± 3.75mm; range, 2.0 – 14.4mm)
and the remaining 14 showed a combination of the two patterns
(mean increase of nodule size, 4.5 ± 1.78mm; range, 2.3 – 8.5mm;
mean increase of solid component, 3.84 ± 2.44mm; range, 2.1 –
9.2mm). In the interval growth group, median time interval between
initial CT and occurrence of interval growth / surgical resection were
527 days (range, 90 – 1281 days) and 579.5 days (range, 91 – 3255
days), respectively. For reference, median time interval between last
pre-operative CT and surgery was 8 days (range, 1 – 73 days) for
interval growth group. And the median time interval between last
pre-operative CT scans and surgical resections was 17 days (range, 0
– 76 days) in the immediate surgery group. On the last CT before
surgery, size of solid component of interval growth group (4.44 ±
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2.76mm; range, 1.5 – 16.9mm) was significantly larger than that of
immediate surgery group (3.49 ± 1.01mm; range, 1.6 – 5.6mm;
p=0.02) though size of PSNs did not show difference (interval growth
group, 14.76 ± 5.06mm; immediate surgery group, 14.54 ± 5.50mm; p
= 0.823). Surgical and pathological results for these 125 nodules were
summarized in the table 6. There were five PSNs with invasion of
visceral pleura and no PSN with lymphatic or vascular invasion.
The median follow-up periods after surgical resection were 957.5
days (range, 158 – 2365 days) and 1277 days (range, 179 – 2543
days) in the interval growth group and immediate surgery group,
respectively. In the interval growth group, five PSNs showed clinical
stage shift based on the size of whole nodule during preoperative
follow-up period (initial size, 16.68 ± 3.01mm; range 13 – 20mm; size
after interval growth, 22.92 ± 2.57mm; range, 20.3 – 27mm), in
which tumor stage did not change based on their solid components’
size (initial solid size, 2.68 ± 0.83mm; range 1.4 – 3.5mm; solid size
after interval growth, 4.12 ± 1.42mm; range, 3.2 – 6.6mm). These
five PSNs were clinical stage T1a on initial chest CT, which
progressed as clinical stage T1b after interval growth, which were
pathologically confirmed as adenocarcinoma (n=2), MIA (n=2), and
AIS (n=1).
There were five equivocal cases (4.0%) in which recurrences
occurred or not among 125 individuals. The profile of theses five
cases is summarized in table 7. Otherwise, there was no recurrence
on their post-operative follow-ups. Even if these 5 equivocal cases
were actually recurrences, there was no significant recurrence
difference between interval growth group and immediate surgery
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group (adjusted hazard ratio (HR) = 0.455; 95% confidence interval
(CI), 0.050 – 4.156; p=0.485). For survival analysis, four individuals
died (interval growth group, n=1; immediate surgery group, n=3).
There was no significant difference in the respect of survival (HR =
0.068; 95% CI, 0.001 – 3.616; p=0.185) (figure 3). For reference, five
individuals with above-mentioned PSNs of clinical stage shifts had
not equivocalness of recurrence or death.
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DISCUSSION
In our study, we found that lung cancer history, part-solid GGNs,
and the diameter of SSNs were significant predictors for the growth
of SSNs with solid portions ≤ 5 mm. On subgroup analysis, nodule
diameter was observed to be a significant predictor of growth for
both pure GGNs and part-solid GGNs, with lung cancer history
shown to be another significant factor of growth for part-solid GGNs.
Pure GGNs ≥ 10 mm and part-solid GGNs ≥ 8 mm were also
shown to have a significantly higher cumulative percentages of
growth than pure GGNs < 10 mm (p<0.001) and part-solid GGNs <
8 mm (p=0.003), respectively. In addition, we proved that conservative
follow-up until confirmation of interval growth did not result in
disadvantage of recurrence or survival in the PSNs with solid
component ≤ 5mm.
Previous studies (2, 9) have also reported that the size of SSNs was
a significant predictor of nodule growth. Interestingly, Matsuguma et
al. (8) had reported that lung cancer history and nodule size were
significantly associated with nodule growth in pure GGNs, however
they were unable to find any significant predictors for nodule growth
in part-solid GGNs. In our study, nodule diameter was shown to be a
significant predictor of interval growth for both pure GGNs and
part-solid GGNs with solid portions ≤ 5 mm. This discrepancy may
be due to the differences in SSN measurement methods between ours
and the previous study (8). In the previous study (8), the diameter of
SSNs was determined using only the maximal diameter, while we
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recorded the average diameter between the longest diameter and that
of the perpendicular short-axis diameter according to Fleischner
Society recommendations (1). Since the shape of SSNs could
frequently vary and appear as round, oval, or even spiculated rather
than spherical, determination of the diameter using both the largest
and their perpendicular short-axis diameters may better reflect the
actual size of the SSNs than only the maximal diameter. Although it
still remains debatable whether SSNs in patients with a lung cancer
history are second primary lung cancers or metastasis from previous
lung cancers, two previous studies (8, 9) suggested that they may in
fact be second primary lung cancers rather than metastasis.
Hiramatsu et al. reported that none of their patients with lung cancer
history had extrathoracic metastasis or bilateral multiple metastasis
and Matsuguma et al. also reported no recurrence on their patients'
follow-up periods except for only one patient (8, 9). In fact, all five
patients in our study who had a previous history of lung cancer also
showed interval growth of part-solid GGNs without any local
recurrence or other distant metastasis. Nevertheless, it remains
difficult to know confirmatively the exact relationship between lung
cancer history and growing SSNs owing to the lack of a pathological
diagnosis of growing SSNs and the small number of these patients
with both SSNs and previous lung cancer history. Further large
scaled studies would be necessary to address this issue.
In this study, pure GGNs < 10 mm showed a significantly lower
frequency of interval growth than those in the ≥ 10 mm group, with
cumulative percentages of 1.9%, 4.0%, 10.9%, 13.5%, 13.5% at 1, 2, 3,
4, and 5 year follow-ups, respectively. Therefore, considering their
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very slow growth rate (17) and the low incidence of interval growth,
pure GGNs < 10 mm may be best followed-up biennially after
one-year follow-up. Through the one-year follow-up, rapidly growing
pure GGNs, which may be biologically more aggressive and thus
clinically relevant malignancies, could be avoided from being missed,
while subsequent biennial follow-ups can reduce the cumulative
radiation dose as well as the monetary burden of the patients without
missing the growth of relatively indolent pure GGNs. Although there
may be nodules that show interval growth at second-year follow-up
CTs without detectable growth on first year follow-up, we believe
that as their growth rate may be low, the chance of a significant
delay in the diagnosis of clinically relevant malignancies would not be
substantially high.
The annual cumulative percentages of growing pure GGNs ≥ 10
mm in our study was 12.9%, 30.4%, 42.0%, 42.0%, 71.0% at 1, 2, 3, 4,
5 year follow-ups, and this frequency is thought to be substantial.
Previous studies have reported that the growth of SSNs was
typically observed within the first 3 years in large pure GGNs (6, 8),
and revealed that pure GGNs ≥ 10 mm may frequently be invasive
adenocarcinomas pathologically (16, 19). In this context, for pure GGN
≥ 10 mm, annual follow-up CT may be reasonable, as recommended
by the management guidelines of the Fleischner Society (1). For
part-solid GGNs with solid portions ≤ 5 mm, interval growth can
occur frequently regardless of their diameter. Therefore, we believe
that annual surveillance should not be skipped for these persistent
part-solid GGNs. Particularly, in the case of part-solid GGNs ≥ 8
mm, their interval growth was observed to occur consistently and
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frequently (11.5%, 38.0%, 43.6%, 78.9%, 78.9% at 1, 2, 3, 4, and 5
year follow-ups, respectively) and approximately 80% of these
nodules grew in 4 year follow-ups. Thus, immediate surgical
resection of theses nodules may not be unreasonable after
confirmation of their persistency.
With respect to prognosis comparison study, five PSNs with solid
component ≤ 5mm showed clinical stage shift during the follow-up
period before confirmation of interval growth. These 5 nodules were
demonstrated as clinical stage T1a on initial chest CT, which shifted
to clinical stage T1b after interval growth and turned out as
adenocarcinoma (n=2), MIA (n=2), and AIS (n=1), pathologically. In
spite of stage shift during follow-up, however, five individuals who
had these five nodules did not show disease recurrence after surgery
or die. It could be because surgical resection for theses nodules were
performed too early state to change patients’ prognosis, considering
three of these five PSNs consisted of MIA or AIS. It is widely
accepted that size of tumor is important for the prognosis prediction
of the patient with lung cancer (26). And according to previous
study, size of solid part is better prognostic factor than nodule size in
part-solid GGN (27). As suggested by previous study (27), if clinical
stages for these five PSNs are applied with solid part instead of
nodule size, they are all T1a without stage shift even after interval
growth. Considering this result, the fact that recurrence or death did
not occur in these five nodules can be explainable.
Meanwhile, when sizes of PSNs and solid components within them
were adjusted to minimize different baseline characteristics between
the two groups in the present study, recurrence and survival were
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comparable between the two. In addition, sizes of PSNs on the last
preoperative CT and pathologic sizes of the lesions reflecting actual
pathologic tumor sizes were not significantly different between the
two groups. In this context, nodules’ size itself can be better than the
presence of interval growth in terms of prognosis of patients with
PSN with solid component ≤ 5mm. However, although sizes of solid
components were different on the last preoperative CT between the
two groups with increased size of solid components in the interval
growth group, the patient’s prognosis was not significantly influenced
by it, unlike previous study (27). It may be because a little increases
in solid component’ size may not actually have significant effect on
patient’s prognosis to a certain degree. Actually, sizes of solid
components in the two groups are less than 10mm even on the last
pre-operative CT. Further large scaled studies would be necessary to
address this issue clearly.
Several limitations of our study should be mentioned. First, this
study was of retrospective design, and CT examinations or patients’
management were not uniformly performed. Second, in spite of our
relatively large study population, the number of growing nodules was
relatively small. Third, follow-up of SSNs was not uniform or quite
long. Fourth, we selected dominant nodules in one patient who had
multiple SSNs as dominant nodules are generally regarded to
determine a patient's outcome and further management (1). However,
there may have been the possibility that non-dominant nodules would
show a different gwth rate or tendency than dominant lesions. Fifth,
study population of prognosis comparison study was limited to
surgically resected PSNs with solid component ≤ 5mm. There must
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be PSNs with solid component ≤ 5mm which were not resected
though they showed interval growth. Sixth, all SSNs showing
interval growth in our study were not resected nor were they
diagnosed pathologically, owing to patient's refusal of surgery or loss
of follow-up. Lastly, there were five equivocal cases which had
recurrence or not in prognosis comparison study.
In conclusion, natural course of SSNs with solid portions ≤ 5 mm
significantly differed according to nodule type and nodule diameters,
with which their managements can be subdivided. And “follow-up
and surgical resection after interval growth” did not show negative
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Synchronous 53 / 77 (68.8%) Pure GGN 136 (63.8%)















Table 1. Baseline clinical and radiological characteristics
of 213 patients and their 213 persistent pulmonary SSNs
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Note - Data are median (range) or mean ± standard deviation
(range) or numbers (percentage).
*All 16 patients had history of surgically resection of lung cancer or
their preinvasive lesion (Invasive adenocarcinoma in 14,
adenocarcinoma-in-situ in 2).
SSN, Subsolid nodule; GGN, Ground-glass nodule RUL, Right upper
lobe; RML, Right middle lobe; RLL, Right lower lobe; LUL, Left
upper lobe; LLL, Left lower lobe.
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Variables







Sex Male 45 0.674
Female 91






































Table 2. Univariate and multivariate analyses on the
growth of persistent pure GGNs









Cumulative number of growing nodules
(cumulative percentages of growing
nodules)
P-value
















































































Table 3. Annual cumulative number and percentages of
growing nodules according to nodule diameter for pure
GGNs and part-solid GGNs with solid portions ≤ 5 mm









P-value HR 95% CI P-value
Sex Male 27 0.517
Female 50
















































Table 4. Univariate and multivariate analyses on the
growth of persistent part-solid GGNs with solid portions
≤ 5 mm




















No 34 (63.0%) 53 (74.6%) 0.159
Yes 20 (37.0%) 18 (25.4%)
Smoking
history
Never 40 (74.1%) 61 (85.9%) 0.096







































Diameter (mm) 11.48 ± 4.78 14.44 ± 5.4 0.002
Size of solid component
(mm)
2.53 ± 0.91 3.19 ± 0.95 <0.001
Table 5. Baseline clinical characteristics of 125
individuals and initial CT features of their part-solid
nodules with solid component ≤ 5 mm
RUL, right upper lobe; RML, right middle lobe; RLL, right lower












22 (40.7%) 18 (25.4%) 0.112
Segmentec
tomy
7 (13.0%) 7 (9.9%)
Lobectomy 25 (46.3%) 46 (64.8%)
Pathological
size (mm)




No 45 (83.3%) 64 (90.1%) 0.259
Not
evaluate




Tis 20 (37.0%) 25 (38.5%) 0.285
T1a 32 (59.3%) 33 (50.8%)
T1b 0 (0%) 4 (6.2%)
T2a 2 (3.7%) 3 (4.6%)
Pathology Pre-invasi
ve lesion
20 (37.0%) 31 (43.7%) 0.232




25 (46.3%) 35 (49.3%)
Table 6. Surgical and pathological results of 125 part-solid
nodules with solid component ≤ 5 mm
Pre-invasive lesion including atypical adenomatous hyperplasia and
adenocarcinoma in-situ








case 1 17.4 mm (3.7 mm) Lung nodule
Patient had second primary
cancer (cholangiocarcinoma)
case 2 28.6 mm (4.5 mm) Pleural lesion
Patient had adjuvant
chemotreatment
case 3 7.5 mm (2.0 mm) Lung nodule















Table 7. Profile of five cases which were equivocal in
aspect of recurrence among 125 part-solid nodules with
solid component ≤ 5 mm
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Figure 1. Flowchart showing how study population was selected and
its retrospective manner. Numbers in parentheses are the numbers of
the part-solid nodules with solid component ≤ 5 mm.
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Figure 2. Kaplan-Meier plot for time to nodule growth according to
nodule type in the SSNs (a), nodule diameter in pure GGN group (b)
and nodule diameter of part-solid GGN group (c). (a) Part-solid
GGNs show significantly higher cumulative percentages of growth
than pure GGNs. (b) In subgroup analysis, pure GGNs ≥ 10 mm
show significantly higher cumulative percentages of growth than pure
GGNs < 10 mm. (c) Part-solid GGNs with solid portions ≤ 5 mm
were best subcategorized with the cut-off diameter value of 8 mm in
terms of cumulative percentages of growing nodules, and those ≥ 8







Figure 3. Plots for time to overall survival after surgical resection of
persistent part-solid nodule with solid component ≤ 5 mm. No
significant difference is noted in the respect overall survival (p=0.185)
between interval growth group and immediate surgery group.
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요약 (국문초록)
5mm 이하의 고형 성분을 가지는





목적 : 이 연구의 목적은 고형 성분이 5mm 이하인 폐 아고형 결절의
자연경과 확인과, 5mm 이하의 고형 성분을 지니는 부분 고형 결절에
대하여 성장을 보일 때까지 기다린 후 수술적 치료를 하는 것이 환자의
예후에 나쁜 영향을 미치는지 확인하는 것이다.
방법 : 2005년부터 2013년까지 213명의 환자에게서 얻은 5mm 이하의
고형 성분을 지니는 아고형 결절들을 대상으로 그 자연경과를
확인하고자 하며, 이와는 별개로, 125명의 환자에게서 얻은 125개의 부분
고형 결절을 대상으로 성장을 보일 때까지 기다린 후 수술하는 것이
예후에 어떤 영향을 미치는지 알아보고자 한다. 이는 Kaplan-Meier,
Cox proportional hazard regression, 그리고 Cox-regression analysis를
이용하여 증명하고자 한다.
결과 : 213개의 폐 아고형 결절 중, 136개는 간유리음영 결절 (성장:
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18개; 비성장: 118개)이었고, 77개는 5mm이하의 고형 성분을 가지는
부분 고형 결절 (성장: 24개; 비성장: 53개)이었다. 전체 환자군에서는
폐암의 병력 (p=0.001), 고형 성분의 여부 (p<0.001), 결절 크기
(p<0.001)가 성장을 예측하는 유의한 인자로 밝혀졌다. 결절의 크기는
간유리음영 결절 (p<0.001)과 부분 고형 결절 (p=0.037)들을 나눈 추가
연구에서도 유의한 성장인자로 판명되었고, 폐암의 병력은 부분 고형
결절에서만 또 다른 유의한 인자로 판명되었다 (p=0.002). 10mm 이상의
간유리음영 결절들과 8mm 이상의 부분 고형 결절들은 10mm 미만의
간유리음영 결절들과 8mm 미만의 부분 고형 결절에 비해 유의하게
높은 성장 빈도를 보였다.
예후 관련 연구에 있어서 5mm 미만의 고형 성분을 가지는 125개의
부분 고형 결절 중에 5개의 재발이 의심되는 증례가 있었으나, 이를
실제 재발이라고 하더라도 부분 고형 결절이 성장을 보인 후 수술적
절제를 하는 것이 바로 절제를 하는 것에 비해 무재발 생존 (p=0.485)과
최종 생존율 (p=0.185)에 있어서 의미 있는 차이를 보이지 않았다.
결론 : 5mm 이하의 고형 성분을 가지는 폐 아고형 결절의 자연경과는
고형 성분의 여부, 결절의 크기에 따라 의미 있게 달랐으며, 이를
이용하여 추적검사의 방향을 나눌 수 있을 것으로 기대한다. 또한 5mm
이하의 고형 성분을 가지는 부분 고형 결절의 경우, 성장을 보인 후
수술적 절제를 하더라도 환자의 예후에는 나쁜 영향을 끼치지 않는 것을
확인하였다.
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